强化他汀治疗超高龄缺血性卒中患者的疗效观察 |
| |
引用本文: | 黄元志,刘赟,韦玮.强化他汀治疗超高龄缺血性卒中患者的疗效观察[J].国外医学:物理医学与康复学分册,2018,13(1):16-19. |
| |
作者姓名: | 黄元志 刘赟 韦玮 |
| |
作者单位: | 延安大学医学院;延安大学附属医院神经外科; |
| |
摘 要: | 目的:探讨超高龄缺血性卒中患者应用强化他汀类药物治疗的疗效和安全性。方法:164例超高龄缺血性卒中患者随机分为强化组(阿托伐他汀40 mg/d)80例和对照组(阿托伐他汀20 mg/d)84例,比较2组治疗14 d后血脂及NIHSS评分变化情况,比较2组随访2年后mRS评分、终点事件及不良反应事件的发生情况。结果:治疗14 d后,2组LDL-C血清水平和LDL-C达标率差异均具有统计学意义(P=0.033;P=0.032),2组NIHSS评分差异无统计学意义(P=0.112)。随访2年后,强化组的mRS评分优于对照组(P=0.042),总终点事件发生率低于对照组(P=0.040),2组不良事件发生率的差异无统计学意义(P=0.492)。结论:对于超高龄缺血性卒中患者,强化他汀治疗可安全有效地达到更佳的降脂效果。
|
关 键 词: | 阿托伐他汀 强化他汀 缺血性卒中 超高龄 |
Efficacy of Intensive Statin Therapy in Extreme Elderly Patients with Ischemic Stroke |
| |
Abstract: | To investigate efficacy and safety of intensive statin therapy in extreme elderly patients
with ischemic stroke. Methods: 164 extreme elderly patients with ischemic stroke were randomly divided into
groups intensive(atorvastatin 40 mg/d, n=80) and control(atorvastatin 20 mg/d, n=84). The blood lipid level and
NIHSS score of the two groups were compared 14 days after treatment. Occurrence of endpoint events and adverse reactions were observed by clinical follow-up survey. Results: 14 days after treatment, there was a significant difference between the two groups in serum low density lipoprotein cholesterol (LDL-C) levels and control
rate of LDL-C (P=0.033; P=0.032). There was no difference in NIHSS score (P=0.112). In the 2-year follow-up,
mRS and occurrence of total endpoint events in the intensive group were lower than those in the control group
(P=0.042; P=0.040). No difference was observed in rates of adverse events (P=0.492). Conclusion: For extreme
elderly patients with ischemic stroke, intensive statin therapy can safely and efficiently reduce blood lipid level . |
| |
Keywords: | atorvastatin intensive statin ischemic stroke extreme elderly patients |
本文献已被 CNKI 等数据库收录! |
| 点击此处可从《国外医学:物理医学与康复学分册》浏览原始摘要信息 |
| 点击此处可从《国外医学:物理医学与康复学分册》下载免费的PDF全文 |
|